
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Eradicating HIV-1 infection: seeking to clear a persistent pathogen
Nancie M. Archin, Julia Marsh Sung, Carolina Garrido, et al.
Nature Reviews Microbiology (2014) Vol. 12, Iss. 11, pp. 750-764
Open Access | Times Cited: 268
Nancie M. Archin, Julia Marsh Sung, Carolina Garrido, et al.
Nature Reviews Microbiology (2014) Vol. 12, Iss. 11, pp. 750-764
Open Access | Times Cited: 268
Showing 1-25 of 268 citing articles:
Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection
Rebecca M. Lynch, Eli Boritz, Emily E. Coates, et al.
Science Translational Medicine (2015) Vol. 7, Iss. 319
Closed Access | Times Cited: 428
Rebecca M. Lynch, Eli Boritz, Emily E. Coates, et al.
Science Translational Medicine (2015) Vol. 7, Iss. 319
Closed Access | Times Cited: 428
Precise Quantitation of the Latent HIV-1 Reservoir: Implications for Eradication Strategies
Amanda M. Crooks, Rosalie Bateson, Anna B. Cope, et al.
The Journal of Infectious Diseases (2015) Vol. 212, Iss. 9, pp. 1361-1365
Open Access | Times Cited: 391
Amanda M. Crooks, Rosalie Bateson, Anna B. Cope, et al.
The Journal of Infectious Diseases (2015) Vol. 212, Iss. 9, pp. 1361-1365
Open Access | Times Cited: 391
Targeting the Latent Reservoir for HIV-1
Srona Sengupta, Robert F. Siliciano
Immunity (2018) Vol. 48, Iss. 5, pp. 872-895
Open Access | Times Cited: 314
Srona Sengupta, Robert F. Siliciano
Immunity (2018) Vol. 48, Iss. 5, pp. 872-895
Open Access | Times Cited: 314
Current status and prospects of HIV treatment
Tomás̆ Cihlář, Marshall W. Fordyce
Current Opinion in Virology (2016) Vol. 18, pp. 50-56
Open Access | Times Cited: 302
Tomás̆ Cihlář, Marshall W. Fordyce
Current Opinion in Virology (2016) Vol. 18, pp. 50-56
Open Access | Times Cited: 302
Human Immunodeficiency Virus (HIV)
Transfusion Medicine and Hemotherapy (2016) Vol. 43, Iss. 3, pp. 203-222
Open Access | Times Cited: 294
Transfusion Medicine and Hemotherapy (2016) Vol. 43, Iss. 3, pp. 203-222
Open Access | Times Cited: 294
Anti-HIV Drug Discovery and Development: Current Innovations and Future Trends
Peng Zhan, Christophe Pannecouque, Erik De Clercq, et al.
Journal of Medicinal Chemistry (2015) Vol. 59, Iss. 7, pp. 2849-2878
Closed Access | Times Cited: 289
Peng Zhan, Christophe Pannecouque, Erik De Clercq, et al.
Journal of Medicinal Chemistry (2015) Vol. 59, Iss. 7, pp. 2849-2878
Closed Access | Times Cited: 289
Defining HIV and SIV Reservoirs in Lymphoid Tissues
Claire Deléage, Stephen W. Wietgrefe, Gregory Q. Del Prete, et al.
Pathogens and Immunity (2016) Vol. 1, Iss. 1, pp. 68-68
Open Access | Times Cited: 233
Claire Deléage, Stephen W. Wietgrefe, Gregory Q. Del Prete, et al.
Pathogens and Immunity (2016) Vol. 1, Iss. 1, pp. 68-68
Open Access | Times Cited: 233
Latency reversal and viral clearance to cure HIV-1
David M. Margolis, J. Víctor García, Daria J. Hazuda, et al.
Science (2016) Vol. 353, Iss. 6297
Open Access | Times Cited: 221
David M. Margolis, J. Víctor García, Daria J. Hazuda, et al.
Science (2016) Vol. 353, Iss. 6297
Open Access | Times Cited: 221
HIV persists throughout deep tissues with repopulation from multiple anatomical sources
Antoine Chaillon, Sara Gianella, Simon Dellicour, et al.
Journal of Clinical Investigation (2020) Vol. 130, Iss. 4, pp. 1699-1712
Open Access | Times Cited: 194
Antoine Chaillon, Sara Gianella, Simon Dellicour, et al.
Journal of Clinical Investigation (2020) Vol. 130, Iss. 4, pp. 1699-1712
Open Access | Times Cited: 194
Interval dosing with the HDAC inhibitor vorinostat effectively reverses HIV latency
Nancie M. Archin, Jennifer Kirchherr, Julia Sung, et al.
Journal of Clinical Investigation (2017) Vol. 127, Iss. 8, pp. 3126-3135
Open Access | Times Cited: 176
Nancie M. Archin, Jennifer Kirchherr, Julia Sung, et al.
Journal of Clinical Investigation (2017) Vol. 127, Iss. 8, pp. 3126-3135
Open Access | Times Cited: 176
Blocking type I interferon signaling enhances T cell recovery and reduces HIV-1 reservoirs
Liang Cheng, Jianping Ma, Jingyun Li, et al.
Journal of Clinical Investigation (2016) Vol. 127, Iss. 1, pp. 269-279
Open Access | Times Cited: 167
Liang Cheng, Jianping Ma, Jingyun Li, et al.
Journal of Clinical Investigation (2016) Vol. 127, Iss. 1, pp. 269-279
Open Access | Times Cited: 167
Toll-Like Receptor 7 Agonist GS-9620 Induces HIV Expression and HIV-Specific Immunity in Cells from HIV-Infected Individuals on Suppressive Antiretroviral Therapy
Angela Tsai, Alivelu Irrinki, Jasmine Kaur, et al.
Journal of Virology (2017) Vol. 91, Iss. 8
Open Access | Times Cited: 150
Angela Tsai, Alivelu Irrinki, Jasmine Kaur, et al.
Journal of Virology (2017) Vol. 91, Iss. 8
Open Access | Times Cited: 150
HIV “shock and kill” therapy: In need of revision
Erik Abner, Albert Jordan
Antiviral Research (2019) Vol. 166, pp. 19-34
Closed Access | Times Cited: 142
Erik Abner, Albert Jordan
Antiviral Research (2019) Vol. 166, pp. 19-34
Closed Access | Times Cited: 142
The Latent Reservoir for HIV-1: How Immunologic Memory and Clonal Expansion Contribute to HIV-1 Persistence
Alexandra J. Murray, Kyungyoon J. Kwon, Donna L. Färber, et al.
The Journal of Immunology (2016) Vol. 197, Iss. 2, pp. 407-417
Open Access | Times Cited: 137
Alexandra J. Murray, Kyungyoon J. Kwon, Donna L. Färber, et al.
The Journal of Immunology (2016) Vol. 197, Iss. 2, pp. 407-417
Open Access | Times Cited: 137
Short-Course Toll-Like Receptor 9 Agonist Treatment Impacts Innate Immunity and Plasma Viremia in Individuals With Human Immunodeficiency Virus Infection
Line K. Vibholm, Mariane H. Schleimann, Jesper Falkesgaard Højen, et al.
Clinical Infectious Diseases (2017) Vol. 64, Iss. 12, pp. 1686-1695
Open Access | Times Cited: 133
Line K. Vibholm, Mariane H. Schleimann, Jesper Falkesgaard Højen, et al.
Clinical Infectious Diseases (2017) Vol. 64, Iss. 12, pp. 1686-1695
Open Access | Times Cited: 133
Healing Without Waging War: Beyond Military Metaphors in Medicine and HIV Cure Research
Jing‐Bao Nie, Adam Gilbertson, Malcolm de Roubaix, et al.
The American Journal of Bioethics (2016) Vol. 16, Iss. 10, pp. 3-11
Open Access | Times Cited: 128
Jing‐Bao Nie, Adam Gilbertson, Malcolm de Roubaix, et al.
The American Journal of Bioethics (2016) Vol. 16, Iss. 10, pp. 3-11
Open Access | Times Cited: 128
HIV-1 Reservoirs During Suppressive Therapy
Kirston Barton, Anni Winckelmann, Sarah Palmer
Trends in Microbiology (2016) Vol. 24, Iss. 5, pp. 345-355
Open Access | Times Cited: 117
Kirston Barton, Anni Winckelmann, Sarah Palmer
Trends in Microbiology (2016) Vol. 24, Iss. 5, pp. 345-355
Open Access | Times Cited: 117
Epigenetic control of HIV-1 post integration latency: implications for therapy
Amit Kumar, Gilles Darcis, Carine Van Lint, et al.
Clinical Epigenetics (2015) Vol. 7, Iss. 1
Open Access | Times Cited: 104
Amit Kumar, Gilles Darcis, Carine Van Lint, et al.
Clinical Epigenetics (2015) Vol. 7, Iss. 1
Open Access | Times Cited: 104
Paediatric HIV infection: the potential for cure
Philip Goulder, Sharon R. Lewin, Ellen M. Leitman
Nature reviews. Immunology (2016) Vol. 16, Iss. 4, pp. 259-271
Open Access | Times Cited: 101
Philip Goulder, Sharon R. Lewin, Ellen M. Leitman
Nature reviews. Immunology (2016) Vol. 16, Iss. 4, pp. 259-271
Open Access | Times Cited: 101
CRISPR-mediated Activation of Latent HIV-1 Expression
Prajit Limsirichai, Thomas Gaj, David V. Schaffer
Molecular Therapy (2015) Vol. 24, Iss. 3, pp. 499-507
Open Access | Times Cited: 99
Prajit Limsirichai, Thomas Gaj, David V. Schaffer
Molecular Therapy (2015) Vol. 24, Iss. 3, pp. 499-507
Open Access | Times Cited: 99
LEDGIN-mediated Inhibition of Integrase–LEDGF/p75 Interaction Reduces Reactivation of Residual Latent HIV
Lenard Vranckx, Jonas Demeulemeester, Suha Saleh, et al.
EBioMedicine (2016) Vol. 8, pp. 248-264
Open Access | Times Cited: 97
Lenard Vranckx, Jonas Demeulemeester, Suha Saleh, et al.
EBioMedicine (2016) Vol. 8, pp. 248-264
Open Access | Times Cited: 97
Are T cells the only HIV-1 reservoir?
Abraham J. Kandathil, Sho K. Sugawara, Ashwin Balagopal
Retrovirology (2016) Vol. 13, Iss. 1
Open Access | Times Cited: 96
Abraham J. Kandathil, Sho K. Sugawara, Ashwin Balagopal
Retrovirology (2016) Vol. 13, Iss. 1
Open Access | Times Cited: 96
The Interplay of HIV-1 and Macrophages in Viral Persistence
Chynna M. Hendricks, Thaissa Isaias Cordeiro, Ana Paula Neutzling Gomes, et al.
Frontiers in Microbiology (2021) Vol. 12
Open Access | Times Cited: 76
Chynna M. Hendricks, Thaissa Isaias Cordeiro, Ana Paula Neutzling Gomes, et al.
Frontiers in Microbiology (2021) Vol. 12
Open Access | Times Cited: 76
Engaging innate immunity in HIV-1 cure strategies
Nathan L. Board, Milica Moskovljevic, Fengting Wu, et al.
Nature reviews. Immunology (2021) Vol. 22, Iss. 8, pp. 499-512
Open Access | Times Cited: 70
Nathan L. Board, Milica Moskovljevic, Fengting Wu, et al.
Nature reviews. Immunology (2021) Vol. 22, Iss. 8, pp. 499-512
Open Access | Times Cited: 70
Structure and Dynamics of the Native HIV-1 Env Trimer
James B. Munro, Walther Mothes
Journal of Virology (2015) Vol. 89, Iss. 11, pp. 5752-5755
Open Access | Times Cited: 86
James B. Munro, Walther Mothes
Journal of Virology (2015) Vol. 89, Iss. 11, pp. 5752-5755
Open Access | Times Cited: 86